• Ep 67 - AAM's Craig Burton on Opportunities, Challenges of U.S. Biosimilars Market

  • Sep 5 2024
  • Length: 29 mins
  • Podcast

Ep 67 - AAM's Craig Burton on Opportunities, Challenges of U.S. Biosimilars Market

Listen for free

View show details

  • Summary

  • There is good news in this year’s Association for Accessible Medicines report on savings from biosimilars, including a 30% increase over the last year in savings attributed to biosimilars. The report also explores the economic, policy and regulatory headwinds that are preventing the industry from generating savings at a level that would have a dramatic effect on the U.S. healthcare system.
    In an interview with Washington Editor Steve Usdin on The BioCentury Show, Craig Burton, executive director of AAM’s Biosimilars Council, calls out business practices and government policies that are holding the industry back and discusses the ways a robust biosimilars market could promote biomedical innovation.

    View full story: https://www.biocentury.com/article/653459

    #biotech #biopharma #pharma #lifescience #biosimilars #politics #policy #law

    00:00 - Introduction
    03:45 - IRA
    13:38 - Humira
    20:44 - Biosimilars Pipeline
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Ep 67 - AAM's Craig Burton on Opportunities, Challenges of U.S. Biosimilars Market

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available